Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MELPHALAN vs MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MELPHALAN vs MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN: Safety Overview

Metric MELPHALAN MENINGOCOCCAL POLYSACCHARIDE VACCINE A\NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN
Total FAERS Reports 16,061 175
Deaths Reported 3,369 0
Death Rate 21.0% N/A
Hospitalizations 4,615 45
Average Patient Age 48.1 yrs 35.7 yrs
% Female Patients 43.8% 51.6%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Dr.Reddy's Laboratories Inc N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A